Guy, 12 with his father, is the first child to receive an innovative oral treatment for sleeping sickness, in his hometown Mushie in the Democratic Republic of CongoSleeping Sickness
On December 10, 2020, Sanofi signed a renewed partnership agreement with the World Health Organization to eliminate sleeping sickness by 2030.
The Journey to Eliminate Sleeping Sickness
Breakthrough on Sleeping Sickness
Burden of Neglected Tropical Diseases Mainly Impacts Underserved Populations
Pedriatric Cancers
Sanofi is working to address childhood cancer as a global health issue and to improve survival rates for children with cancer. The Sanofi Corporate Social Responsibility (CSR) Childhood Cancer R&D program focuses on accelerating and developing novel therapies for children with cancer. The philanthropic platform, Foundation S My Child Matters program, is committed to strengthening healthcare and family support for children with cancer in low- and middle-income countries (LMICs).
Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer
My Child Matters: Improving Childhood Cancer Survival in the Developing World
Paediatric polio vaccination, Edéa regional hospital, CameroonPolio
We’re the first global supplier of the injectable polio vaccine and have been fighting to eradicate polio for over 40 years. Since 1988, Sanofi has been a key partner of the Global Polio Eradication Initiative and has supplied billions of doses of Polio Vaccine in the world.
Journey Towards Polio Eradication Over the Last Decade
References
- https://www.who.int/news-room/fact-sheets/detail/cancer-in-children (Accessed March 2021)
- https://www.who.int/news-room/fact-sheets/detail/cancer-in-children (Accessed on March 2023)
- World Health Organization. (2020). Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. World Health Organization. https://apps.who.int/iris/handle/10665/331452 (Accessed March 2023)